EPISODES OF FEVER AND NEUTROPENIA IN CHILDREN WITH CANCER IN A TERTIARY CARE MEDICAL CENTER IN TURKEY
- 1 January 2006
- journal article
- research article
- Published by Informa UK Limited in Pediatric Hematology and Oncology
- Vol. 23 (3), 217-229
- https://doi.org/10.1080/08880010500506719
Abstract
The aim of this study was to determine the clinical features and microbiological spectrum during episodes of fever and neutropenia (FEN) in children with cancer. Demographics, clinical information, treatment approaches, and outcomes of the patients admitted to Akdeniz University Department of Pediatric Hematology and Oncology from October 1996 to June 2004 were evaluated retrospectively. Of the total 621 episodes, 345 (55.5%) were microbiologically documented (MDI) (36.4%) or clinically suspected (CSI) (19.2%) infections. A total of 425 infections were diagnosed in 345 episodes, in which lower respiratory tract infections were the most common (32.7%). Among the microbiologically documented infections, Staphylococci (both coagulase-negative and coagulase-positive) (38.7%) and Escherichia coli (12.9%) were the most frequently isolated gram-positive and gram-negative organisms, respectively. Monocytopenia less than 100/μL (p = 0.01), duration of neutropenia (p =. 01) and fever (p <. 001) were significantly associated with documented infection by univariate analysis. In addition, presence of previous FEN episode (p =. 001) and hypotension (p =. 029) were also found to be risk factors. However, using the multivariate analyses, only the duration of fever was found to be an independent risk factor for MDI. The rate of mortality was significantly higher among under 1-year-old patients (p =. 039). Hypotension and uncontrolled cancer were the significant determinants of poor prognosis. These results may help to consider a more selective management strategy for children with these problems.Keywords
This publication has 19 references indexed in Scilit:
- Evolving concepts of management of febrile neutropenia in children with cancerMedical and Pediatric Oncology, 2002
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerClinical Infectious Diseases, 2002
- Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institutionEuropean Journal Of Cancer, 2001
- Comparison of Cefepime and Ceftazidime in Combination with Amikacin in the Empirical Treatment of High-risk Patients with Febrile Neutropenia: A Prospective, Randomized, Multicenter StudyScandinavian Journal of Infectious Diseases, 2001
- Pseudomonas aeruginosa—Still a Frequent Pathogen in Patients with Cancer: 11‐Year Experience at a Comprehensive Cancer CenterClinical Infectious Diseases, 1999
- A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studiesBritish Journal of Haematology, 1997
- 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverClinical Infectious Diseases, 1997
- ReplyThe Pediatric Infectious Disease Journal, 1995
- Sepsis syndrome and septic shock in pediatrics: Current concepts of terminology, pathophysiology, and managementThe Journal of Pediatrics, 1993
- Three Antibiotic Regimens in the Treatment of Infection in Febrile Granulocytopenic Patients with CancerThe Journal of Infectious Diseases, 1978